Feb 18, 2026 07:19AM
Feb 18, 2026 07:19AM
Feb 12, 2026 06:15PM
Dec 18, 2025 07:31AM
Dec 18, 2025 07:31AM
Nov 13, 2025 05:21PM
Nov 5, 2025 07:16AM Appili Therapeutics announces C$750,000 private placement
Nov 5, 2025 07:16AM
Oct 22, 2025 07:20AM
Oct 1, 2025 07:17AM
Oct 1, 2025 07:17AM
Sep 23, 2025 05:02PM
Sep 23, 2025 05:01PM
Sep 9, 2025 07:20AM Appili Therapeutics to Present Progress on Tularemia Biodefense Vaccine at NATO CBRN Conference
Aug 14, 2025 05:05PM
Jun 25, 2025 06:04PM
Apr 28, 2025 07:41AM
Apr 2, 2025 08:17AM
Mar 18, 2025 07:22AM
Feb 14, 2025 05:06PM
Nov 14, 2024 07:15AM Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
Nov 7, 2024 08:30AM
Nov 6, 2024 08:30AM
Oct 31, 2024 08:30AM
Oct 28, 2024 08:15AM
Oct 17, 2024 07:15AM
Oct 10, 2024 08:15AM
Oct 10, 2024 07:13AM Appili Therapeutics Announces Mailing of the Management Information Circular in Connection with the Special Meeting of Shareholders
Oct 3, 2024 08:15AM
Sep 17, 2024 05:11PM
Aug 13, 2024 05:19PM
Jul 25, 2024 08:30AM
Jun 25, 2024 05:46PM
Apr 2, 2024 08:30AM
Apr 2, 2024 08:30AM Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)
Mar 12, 2024 07:12AM
Dec 15, 2023 07:27AM
Nov 13, 2023 04:24PM
Oct 25, 2023 07:49AM
Sep 27, 2023 07:21PM
Sep 25, 2023 07:54AM
Aug 11, 2023 04:50PM Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2024
Jun 23, 2023 05:07PM
Jun 23, 2023 07:21AM
May 24, 2023 07:19AM
May 8, 2023 07:38AM
Apr 18, 2023 07:17AM
Apr 3, 2023 07:22AM
Feb 14, 2023 07:18AM Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2023
Jan 13, 2023 07:19AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All